News Medical on MSN1h
Novel therapeutic approaches targeting the Wnt pathway in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the deadliest cancers globally, with increasing incidence and mortality rates.
EurekAlert!1d
Unraveling the role of the Wnt pathway in hepatocellular carcinoma: From molecular mechanisms to therapeutic implications
Hepatocellular carcinoma (HCC) is one of the deadliest malignant tumors in the world, and its incidence and mortality have ...
manilatimes9d
Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma
BRISBANE, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology ...
Oncology Nurse Advisor6d
Older Age Predicts Worse Survival in Patients With HCC, Comorbidity Role Unclear
Researchers assessed the prognostic significance of older age and comorbidity burden on overall survival in patients with hepatocellular carcinoma.
Pilot helping hundreds living with liver issues
Hundreds of a people who have chronic liver disease are being helped by an NHS trust's service that helps them attend vital ...
EurekAlert!13d
Two surgeon-scientists receive top national research awards to improve outcomes for SG-prevalent liver and head & neck cancers
Investigator Award has been awarded to two surgeon-scientists at the National Cancer Centre Singapore (NCCS) to pursue novel research in liver cancer and head and neck cancers. Globally, liver cancer ...
Medindia22h
Rznomics Inc. Liver Cancer Drug Candidate Secures Fast Track Designation
Rznomics announced on the 14th that its anticancer drug, RZ-001, has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for the treatment of Hepatocellular Carcinoma (HCC ...